It’s been weeks since the world first learned the name Celeste Rivas Hernandez—a teen missing from Lake Elsinore, ...
Gauteng MEC for Health and Wellness Nomantu Nkomo-Ralehoko has moved to calm fears over delays in pathology results at the ...
Explore practical implications of new research in nephrotic syndrome, from renal biopsy and genetic testing to managing ...
A new Fred Hutch study surprisingly finds that many drugs initially written off as ineffective on cultured cancer cell lines ...
Complete, but not partial, remission was associated with a lower likelihood of doubling of serum creatinine in patients with pure membranous lupus nephritis.
Detailed price information for Halozyme Therapeutic (HALO-Q) from The Globe and Mail including charting and trades.
Purkinje cells, the neurons of the cerebellum, appear to die in an organized pattern, overturning previous beliefs that ...
Opinion
Zacks Investment Research on MSNOpinion

5 Biotech Stocks Worth Adding to Your Portfolio Now

The volatile biotech industry has done reasonably well so far in 2025 amid the ongoing tariff saga. Most pharma/biotech bigwigs are now investing heavily in manufacturing plants/operations in the ...
The company plans to launch in 2026 a program that will provide labs with scanners free of charge in exchange for volume-based payments for biomarker tests.
The synthetic implant may significantly reduce corneal edema without compromising safety, a pilot study shows. In a pilot study, researchers say a particular synthetic endothelial implant for corneal ...
Companion diagnostics (CDx), once considered niche in oncology, are now emerging as a cornerstone of precision medicine ...